$12.5 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 119 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTM | ANTHEM INC | $328,725,000 | +15.8% | 1,250,000 | 0.0% | 2.63% | +8.0% | |
| PLYA | PLAYA HOTELS & RESORTS NV | $110,797,000 | +106.9% | 30,606,930 | 0.0% | 0.89% | +92.8% | |
| ENTA | ENANTA PHARMACEUTICALS INC | $87,868,000 | -2.4% | 1,750,000 | 0.0% | 0.70% | -9.1% | |
| BRMK | BROADMARK RLTY CAP INC | $67,902,000 | +25.9% | 7,170,213 | 0.0% | 0.54% | +17.3% | |
| AGIO | AGIOS PHARMACEUTICALS INC | $66,850,000 | +50.7% | 1,250,000 | 0.0% | 0.54% | +40.4% | |
| GRFS | GRIFOLS S Asp adr rep b nvt | $56,785,000 | -9.4% | 3,113,222 | 0.0% | 0.45% | -15.6% | |
| KARYOPHARM THERAPEUTICS INCnote 3.000%10/1 | $50,287,000 | +1.7% | 35,102,000 | 0.0% | 0.40% | -5.4% | ||
| CARA | CARA THERAPEUTICS INC | $39,330,000 | +29.4% | 2,300,000 | 0.0% | 0.32% | +20.7% | |
| KPTI | KARYOPHARM THERAPEUTICS INC | $25,285,000 | -1.4% | 1,335,000 | 0.0% | 0.20% | -8.2% | |
| BRMK | BROADMARK RLTY CAP INCcall | $22,648,000 | +25.9% | 2,391,536 | 0.0% | 0.18% | +17.5% | |
| INTERCEPT PHARMACEUTICALS INnote 2.000% 5/1 | $18,998,000 | -15.6% | 25,500,000 | 0.0% | 0.15% | -21.2% | ||
| PACB | PACIFIC BIOSCIENCES CALIF IN | $10,350,000 | +12.7% | 3,000,000 | 0.0% | 0.08% | +5.1% | |
| RADIUS HEALTH INCnote 3.000% 9/0 | $5,009,000 | +3.9% | 6,750,000 | 0.0% | 0.04% | -2.4% | ||
| BRMKWS | BROADMARK RLTY CAP INC*w exp 11/15/202 | $2,281,000 | +44.6% | 7,174,613 | 0.0% | 0.02% | +28.6% | |
| GOSS | GOSSAMER BIO INC | $1,300,000 | +28.1% | 100,000 | 0.0% | 0.01% | +11.1% | |
| GOL | GOL LINHAS AEREAS INTELIGENTspon adr pfd new | $582,000 | +58.6% | 85,838 | 0.0% | 0.01% | +66.7% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 41 | Q3 2023 | 3.7% |
| RADIUS HEALTH INC | 33 | Q2 2022 | 1.7% |
| GRIFOLS S A | 33 | Q4 2021 | 0.9% |
| ALPHABET INC | 32 | Q3 2023 | 4.2% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 25.3% |
| VISA INC | 30 | Q3 2023 | 2.9% |
| WABTEC CORP | 27 | Q3 2023 | 3.6% |
| EXELIXIS INC | 27 | Q3 2023 | 2.8% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 2.6% |
| SAVARA INC | 26 | Q3 2023 | 0.3% |
View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Atento S.A. | March 15, 2023 | 2,230,357 | 15.4% |
| Metals Acquisition Corp | February 07, 2023 | 2,489,700 | 9.4% |
| Inflection Point Acquisition Corp. | February 06, 2023 | 1,900,000 | 5.8% |
| AMYRIS, INC. | February 24, 2022 | 1,068,904 | 0.3% |
| Swiftmerge Acquisition Corp. | February 14, 2022 | 291,060 | 1.3% |
| Caribou Biosciences, Inc. | February 11, 2022 | 2,428,150 | 4.0% |
| ENANTA PHARMACEUTICALS INC | February 11, 2022 | 287,000 | 1.4% |
| Protagonist Therapeutics, Inc | February 11, 2022 | 387,051 | 0.8% |
| Solid Power, Inc. | February 11, 2022 | ? | ? |
| Better Therapeutics, Inc. | February 09, 2022 | 124,065 | 0.5% |
View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR/A | 2024-02-12 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-23 |
View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.